work on women
By Christopher Smeenk
Viagra, the drug being blamed for the revival of venereal
diseases among Florida’s retirement population, has been
found ineffective in the treatment of female sexual arousal
According to a press release from Pfizer, the creator of Viagra,
pharmaceutical studies concluding this month suggest the efficacy
of Viagra in treating FSAD is dubious.
“The results do not mean that Viagra doesn’t help
to treat FSAD, but they do not support a regulatory filing,” said
Kate Robins, a spokesperson for Pfizer. She indicated the company
would not continue researching treatment of FSAD with Viagra.
“FSAD is not simply the female equivalent of erectile
dysfunction,” Robins said. “It’s an incredibly
complex set of symptoms and causes that are difficult to evaluate
FSAD is characterized by a persistent inability to attain
or maintain sexual excitement and may create emotional difficulties,
Robins explained. The condition is believed to result from
a broad range of medical and psychological conditions, she
said, adding diagnosis of FSAD involves assessing physical,
emotional and relationship factors.
“The whole notion that women and men experience sexuality
in the same way was horribly misguided,” commented Abbie
Lippman, chair of the Canadian Women’s Health Network.
“The whole thing is a construct of the pharmaceutical
industry and medical community designed to pathologize women’s
sexual experience,” said Leonore Tiefer, a leading women’s
“Pfizer has changed the expectations that men have about
their erections through advertising and press releases,” Tiefer
explained. “Women don’t materialize their sexual
arousal in the same way.
“Doctors fix things that are broken,” she said,
arguing the failure of a woman or man to become aroused does
not necessarily indicate the presence of a physical problem. “To
find out what arouses a woman, you just have to ask them.”